Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study

Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study

BackgroundUrinary 11‐dehydro‐thromboxane (TX)B2 has been described as a potential predictive biomarker of major adverse cardiovascular events (MACEs) in high cardiac risk patients. This part of LTIMI (Leukotrienes and Thromboxane In Myocardial Infarction) study aimed to evaluate the relationship bet...

Full description

Bibliographic Details
Main Authors: Wojciech Szczeklik, Edyta Stodółkiewicz, Marcin Rzeszutko, Marek Tomala, Anton Chrustowicz, Krzysztof Żmudka, Marek Sanak
Format: Article
Language:English
Published: Wiley 2016-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atherosclerosis
complication
inflammation
myocardial infarction
risk factor
thromboxane
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.003702

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.116.003702

Similar Items